Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray technology--an intellectual property retrospective.

Richard Rouse1, Gary Hardiman

  • 1Biomedical Genomics Facility (BIOGEM), Division of Biology, University of California San Diego, La Jolla, CA 92093-0349, USA.

Pharmacogenomics
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The northern fulmar as a sentinel species for monitoring the environmental health impacts of plastic exposure.

Journal of toxicology and environmental health. Part B, Critical reviews·2026
Same author

Multiscale Modeling and Systems Biology in Microgravity Investigations.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Fusion genes in precision oncology: prostate cancer as a diagnostic case study.

Expert review of molecular diagnostics·2026
Same author

Transcriptomic Responses of Zebrafish Embryos to Environmentally Relevant, Low-Dose (2-Ethylhexyl) Phthalate Exposure at 96-120 hpf.

Genes·2026
Same author

A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma.

medRxiv : the preprint server for health sciences·2025
Same author

Targeted complement inhibition ameliorates the pathological and cognitive outcomes in repetitive mild closed head injury.

Signal transduction and targeted therapy·2025

Microarray technology, essential for understanding gene function and drug development, has evolved significantly. Key patents and legal disputes have shaped its commercial and clinical applications.

Area of Science:

  • Genomics
  • Biotechnology
  • Pharmacogenomics

Background:

  • The human genome sequencing project provides a foundation for identifying drug targets and understanding genetic factors in drug metabolism and toxicity.
  • Microarrays are a key technology for linking gene sequence to biological function.
  • Applications span disease diagnosis, pharmacogenomics, and toxicogenomics, with growing market opportunities.

Purpose of the Study:

  • To provide a retrospective review of microarray technology.
  • To highlight significant patents and litigation impacting the microarray industry.

Main Methods:

  • Review of historical data, patent filings, and legal case records related to microarray technology.
  • Analysis of industry trends and market evolution.

Related Experiment Videos

Main Results:

  • Microarray technology has advanced significantly, bridging the gap between gene sequence and function.
  • Intellectual property rights and litigation have influenced the technology's development and commercialization.
  • Innovation continues in both public and private sectors as the field matures.

Conclusions:

  • Microarray technology is a vital tool in modern biological and medical research.
  • The landscape of intellectual property has played a crucial role in shaping the microarray industry.
  • Future innovations are expected to further enhance microarray applications in clinical settings.